278788-66-2 Usage
Uses
Used in Pharmaceutical Industry:
(R)-3-HYDROXYMETHYL-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER is used as a building block for the preparation of PI3K inhibitors for rheumatoid arthritis treatment. Its incorporation into these inhibitors allows for the development of targeted therapies that can effectively manage the symptoms and progression of rheumatoid arthritis.
Used in Antimalarial Agents:
In the field of antimalarial drug development, (R)-3-HYDROXYMETHYL-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER is utilized in the synthesis of benzoxaborole derivatives. These derivatives exhibit potent antimalarial activity, offering a promising avenue for the creation of new treatments to combat malaria.
Used in Anti-tuberculosis Agents:
Similarly, this compound is employed in the production of benzoxaborole derivatives that possess anti-tuberculosis properties. The development of these agents is crucial in the ongoing fight against tuberculosis, a disease that continues to affect millions of people worldwide.
Check Digit Verification of cas no
The CAS Registry Mumber 278788-66-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,7,8,7,8 and 8 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 278788-66:
(8*2)+(7*7)+(6*8)+(5*7)+(4*8)+(3*8)+(2*6)+(1*6)=222
222 % 10 = 2
So 278788-66-2 is a valid CAS Registry Number.
InChI:InChI=1/C10H20N2O3/c1-10(2,3)15-9(14)12-5-4-11-8(6-12)7-13/h8,11,13H,4-7H2,1-3H3/t8-/m1/s1
278788-66-2Relevant articles and documents
FARNESYL PROTEIN TRANSFERASE INHIBITORS
-
Page/Page column 35, (2010/02/11)
Disclosed are compounds of formula (1.0), wherein R represents a cyclic moiety to which is bound an imodazolylalkyl group; R represents a carbamate, urea, amide or sulfonamide group; and the remaining substituents are as defined herein. Also disclosed is a method of treating cancer and a method of inhibiting farnesyl protein transferase using the disclosed compounds.